Need to keep on prime of the science and politics driving biotech in the present day? Enroll to get our biotech publication in your inbox.
Good day from ASH! Scripting this Readout from a press room on the annual hematology confab right here in San Diego. In the present day’s version is chockfull of Vertex content material, plus some extras from ASH and elsewhere.
Vertex’s Joshua Boger is colourful
Joshua Boger, founding father of Vertex Prescription drugs, nonetheless finds the corporate’s new sickle cell approval flabbergasting: “I’d have misplaced a home in a bar wager if I had wager that Vertex can be the primary firm to carry a CRISPR drug to the world,” he instructed STAT. In a wide-ranging interview, Boger — who stepped down from his helm in 2017 after 28 years there — spoke about his work at Vertex, how he imagines biotech’s future, and what he thinks of Elon Musk. (Spoiler: He’s “extraordinarily bizarre. He simply doesn’t join with folks.”)
Get limitless entry to award-winning journalism and unique occasions.
Subscribe